BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32748777)

  • 1. Case Report: Rifampicin-Induced Thrombocytopenia in a Patient with Borderline Lepromatous Leprosy.
    Shui T; Shi C; Jing Z; Yang D; Zhu J
    Am J Trop Med Hyg; 2020 Oct; 103(4):1441-1442. PubMed ID: 32748777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immuno-allergic accidents with rifamipcin].
    Flageul B; Wagner L; Cottenot F
    Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampicin-induced erythema nodosum leprosum-like eruption in borderline lepromatous leprosy.
    Karthikeyan K; Thappa DM; Kadhiravan T
    Indian J Lepr; 2001; 73(2):167-9. PubMed ID: 11579653
    [No Abstract]   [Full Text] [Related]  

  • 4. Type I reaction in a borderline leprosy case successfully treated with multidrug therapy and ofloxacin.
    Asz-Sigall D; López-García L; Neme-Yunes Y; Yuen-Palos R; Vega-Memije ME; Arenas R
    Int J Dermatol; 2008 Oct; 47(10):1084-6. PubMed ID: 18986365
    [No Abstract]   [Full Text] [Related]  

  • 5. Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy.
    Rea TH
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):129-35. PubMed ID: 11036492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombocytopenic purpura with blood blisters on once a month rifampicin.
    Selwyn GJ; Jayakumar A; Samson PD
    Indian J Lepr; 1996; 68(4):371-2. PubMed ID: 9001906
    [No Abstract]   [Full Text] [Related]  

  • 7. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new short-term combination therapy of leprosy.
    Freerksen E; Alvarenga AE; Leguizamon O; de Morra MV; Reyes LA; von Ballestrem W
    Chemotherapy; 1991; 37(5):353-63. PubMed ID: 1804596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of decline in bacterial index in leprosy; observations after three different chemotherapeutic interventions.
    Ganapati R; Pai VV; Shroff HJ; Gandewar K
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):264-6. PubMed ID: 9251604
    [No Abstract]   [Full Text] [Related]  

  • 10. Relapse in a borderline-tuberculoid case of leprosy 5 years after the release from rifampicin monotherapy.
    Shetty VP; Antia NH
    Lepr Rev; 1997 Jun; 68(2):162-6. PubMed ID: 9217356
    [No Abstract]   [Full Text] [Related]  

  • 11. Controlled clinical trial of two multidrug regimens with and without rifampin in highly bacilliferous BL/LL south Indian patients: a five-year report.
    Thomas A; Balakrishnan A; Nagarajan M; Prabhakar R; Tripathy SP; Christian M; Somasundaram PR
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):273-80. PubMed ID: 2198314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic prospects for paucibacillary leprosy.
    Katoch K
    Indian J Lepr; 2000; 72(3):351-61. PubMed ID: 11105276
    [No Abstract]   [Full Text] [Related]  

  • 13. Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
    Sehgal VN; Kumar S; Jain S; Bhattacharya SN
    J Dermatol; 1998 Jan; 25(1):63-5. PubMed ID: 9519615
    [No Abstract]   [Full Text] [Related]  

  • 14. Borderline Lepromatous Leprosy with Type 1 (Reversal) Reactions in a Chinese Man.
    Fu X; Liu H; Zhang F
    Am J Trop Med Hyg; 2015 Aug; 93(2):207-209. PubMed ID: 26251526
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of post-partum borderline tuberculoid leprosy complicated by a median nerve abscess, peptic ulceration and rifampicin-induced haemolytic renal failure.
    Dawe S; Lockwood DN; Creamer D
    Lepr Rev; 2004 Jun; 75(2):181-7. PubMed ID: 15282971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients.
    Pritze S; Alvarenga AE; Leguizamon O; Haubitz I
    Chemotherapy; 1989; 35(5):373-82. PubMed ID: 2676405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
    Young RJ; Gilson RT; Elston DM
    Cutis; 2000 Apr; 65(4):203-6. PubMed ID: 10795079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
    Suneetha S; Reddy R
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):53-4. PubMed ID: 11480321
    [No Abstract]   [Full Text] [Related]  

  • 19. Two multidrug fixed-dosage treatment regimens with multibacillary leprosy patients.
    Gallo ME; Alvim MF; Nery JA; Albuquerque EC; Sarno EN
    Indian J Lepr; 1996; 68(3):235-45. PubMed ID: 8889609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse alopecia of the scalp in borderline-lepromatous leprosy in an Indian patient.
    Abraham S; Ebenezer GJ; Jesudasan K
    Lepr Rev; 1997 Dec; 68(4):336-40. PubMed ID: 9503871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.